Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.


Figure 5


Figure 5 Positron emission tomography (PET) images from patients with unstable carotid disease after administration of fluorine-18–labeled deoxyglucose (FDG). (A) FDG-PET (left column), computed tomography (CT) angiography (middle column), and fused (right column) images from patient with symptomatic carotid stenosis (top row) and contralateral asymptomatic carotid stenosis (bottom row). The yellow arrows highlight areas of FDG uptake corresponding to stenotic carotid plaque. (B) A graph showing FDG accumulation rate in symptomatic versus asymptomatic carotid plaques. Note that FDG uptake into symptomatic plaque was significantly higher. Modified, with permission, from original figure by Rudd et al. (39).





Right arrow Return to article

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement